35 Stocks Moving In Friday's Mid-Day Session

Gainers

  • Ceragon Networks Ltd. (NASDAQ:CRNT) shares surged 54.6% to $4.8699. Ceragon Networks is expected to release its Q4 earnings results on Monday, February 8, 2021.
  • ObsEva SA (NASDAQ:OBSV) shares jumped 52.7% to $3.8468 after jumping over 19% on Thursday. ObsEva recently provided updates on Yselty clinical development program.
  • Charah Solutions, Inc. (NASDAQ:CHRA) shares climbed 43% to $3.875 after the company announced it has been awarded a 12-year ash marketing contract by Dominion Energy for beneficial use of 8.1 million tons of reclaimed ponded coal ash.
  • Atlantic Power Corporation (NYSE:AT) shares gained 40.7% to $2.9550 as the company agreed to be acquired by I Squared Capital, a leading global infrastructure investor.
  • Polar Power, Inc. (NASDAQ:POLA) shares gained 36.2% to $12.00.
  • DBV Technologies S.A. (NASDAQ:DBVT) shares climbed 35% to $5.05 after the company issued an update on investigational viaskin peanut for children ages 4-11 years.
  • Foresight Autonomous Holdings Ltd. (NASDAQ:FRSX) rose 30.7% to $8.56. Foresight Autonomous’s Eye-Net Mobile subsidiary recently initiated a pilot project with a global Japanese vehicle manufacturer.
  • Glory Star New Media Group Holdings Limited (NASDAQ:GSMG) gained 30.6% to $3.54.
  • IKONICS Corporation (NASDAQ:IKNX) surged 22.9% to $12.78.
  • DPW 13D filing from IKONICS showed a 7.12% stake in the company.
  • Pioneer Power Solutions, Inc. (NASDAQ:PPSI) climbed 22% to $6.52.
  • BioVie Inc. (NASDAQ:BIVI) surged 20% to $35.87 after B. Riley FBR initiated coverage on the stock with a Buy rating and announced a $47 price target.
  • Bionano Genomics, Inc. (NASDAQ:BNGO) climbed 18.7% to $8.25 after jumping over 23% on Thursday. The company regained compliance with Nasdaq minimum bid price listing requirement. The company highlighted, at its Cytogenomics Symposium, users experiences with Saphyr.
  • Rekor Systems, Inc. (NASDAQ:REKR) gained 17.8% to $10.49.
  • LightPath Technologies, Inc. (NASDAQ:LPTH) surged 16.2% to $4.8822. LightPath Technologies announced a new European sales office.
  • Yield10 Bioscience, Inc. (NASDAQ:YTEN) gained 16% to $9.00.
  • Burning Rock Biotech Limited (NASDAQ:BNR) gained 15.7% to $31.84 after gaining over 10% on Thursday.
  • BlackBerry Limited (NYSE:BB) gained 14.5% to $10.43 after the company sold 90 patents linked to smartphone technology to China’s Huawei, according to the U.S. Patent and Trademark Office records cited by Canada’s The Globe and Mail newspaper.
  • Boxlight Corporation (NASDAQ:BOXL) surged 13% to $2.3699 after jumping around 15% on Thursday.
  • Tufin Software Technologies Ltd. (NYSE:TUFN) rose 12.2% to $17.25 after the company raised preliminary Q4 sales guidance. The company also named Raymond Brancato as Chief Revenue Officer.
  • Accolade, Inc. (NASDAQ:ACCD) shares rose 10.8% to $52.91 after the company confirmed it will buy telemedicine start-up 2nd.MD.
  • Jounce Therapeutics, Inc. (NASDAQ:JNCE) surged 10.4% to $8.57. Jounce Therapeutics recently announced initiation of Phase 1 INNATE study of JTX-8064 monotherapy and PD-1 inhibitor combination therapy in patients with advanced solid tumors.
  • Chuy's Holdings, Inc. (NASDAQ:CHUY) gained 9.9% to $33.36 after Stifel upgraded the stock from Hold to Buy and raised its price target from $23 to $40.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!


Check out these big penny stock gainers and losers

Losers

  • Dogness (International) Corporation (NASDAQ:DOGZ) shares dipped 22.5% to $2.09 after jumping 23% on Thursday. Dogness recently said it experienced strong holiday sales.
  • Cardiff Oncology, Inc. (NASDAQ:CRDF) fell 21.8% to $15.31. The company presented data that continues to demonstrate the clinical benefit of Onvansertib in KRAS-mutated mCRC and initial findings from expanded access program.
  • SOS Limited (NYSE:SOS) fell 20.2% to $2.21 after the company reported exercise of warrants for $26.6 million gross proceeds.
  • Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) dipped 14.8% to $7.67.
  • Poshmark, Inc. (NASDAQ:POSH) dipped 14.8% to $86.47. Poshmark shares climbed around 142% on Thursday as the company priced its IPO at $42 per share.
  • Voxeljet AG (NASDAQ:VJET) fell 13.9% to $14.64 after the company reported a roughly €1.451 billion offering of ordinary shares.
  • Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) tumbled 13.1% to $6.99. Lexicon Pharmaceuticals recently announced it received FDA regulatory feedback that the results of its SOLOIST and SCORED Phase 3 clinical studies can support a new drug application submission.
  • Versus Systems Inc. (NASDAQ:VS) dropped 12.8% to $7.20. Versus Systems priced its public offering of 1,280,000 units at a of USD $7.50 per unit.
  • Sino-Global Shipping America, Ltd. (NASDAQ:SINO) dipped 12.7% to $2.96 after gaining over 23% on Thursday.
  • Progress Software Corp (NASDAQ:PRGS) fell 10.2% to $43.83. Progress Software reported better-than-expected results for its fourth quarter, but issued weak forecast for the current quarter.
  • GrafTech International Ltd. (NYSE:EAF) fell 8.7% to $10.60 after the company reported a secondary offering of common stock of 20 million shares.
  • 3D Systems Corporation (NYSE:DDD) shares fell 8.5% to $29.28 after jumping 36% on Thursday. 3D Systems recently issued strong Q4guidance.
  • AirNet Technology Inc. (NASDAQ:ANTE) shares fell 6.5% to $2.43 after gaining 7% on Thursday. The company, last week, entered into investment agreement with Unistar Group Holdings Ltd.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasBiotechnologyElectronic Equipment ManufacturersHealth CareInformation TechnologyMid-Day MoversTop Gainers